Some Duopharma products
KUALA LUMPUR: Duopharma Biotech Bhd
, which recorded stronger earnings in the third quarter ended Sept 30, will push ahead with its foray into specialty products as one of its strategies to create a pool of niche products.
The company in a statement yesterday said that it had recently obtained registration approval and launched Erysaa, an Erythropoeitin (EPO) product. EPO is the protein present in the human body that adjusts the red blood cell generation in accordance with the oxygen requirement of the human body.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
